Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
The SMAC mimetic LCL-161 selectively targets JAK2V617F mutant cells.
Journal: Experimental hematology & oncology
Published: November 02, 2019
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm.
Journal: Journal of visualized experiments : JoVE
Published: January 07, 2017
JAK2(V617I) results in cytokine hypersensitivity without causing an overt myeloproliferative disorder in a mouse transduction-transplantation model.
Journal: Experimental hematology
Published: May 22, 2015
Showing 1-4 of 4
Last Updated: 09/26/2026